HEOR (2)

States Feeling Budget Pressures Due to Expanding Medicaid Enrollment Economic recession effects induced by state and local public policy responses to the COVID-19 pandemic (according to the ...

Importation of Price Controls on Medicare Part B and D Drugs – Interpretation and Implementation The Trump administration recently announced through an executive order that the cost of ...

Choosing Between Food and Medicine The COVID-19 induced recession has taken another ominous turn as the Census Bureau recently reported that almost 30 million Americans responded in a ...

Many in the pharma industry currently fear that the broad use of price controls, once thought of as being theoretical and a remote possibility, is now an inevitability. This author has ...

This blog is the second of a two-part series and highlights two of the four key forces driving changes in the healthcare ecosystem, encouraging medical device companies to rethink their ...

In the first blog of this two-part series, we highlight two of the four key forces driving changes in the healthcare ecosystem, encouraging medical device companies to rethink their ...

When new drugs enter the market, there are often delays before patients have access to the medication. These delays are partly due to patients and physicians being required to complete ...

Estimating the size of a target patient population is critical for many stakeholders within the healthcare industry. For pharmaceutical companies, a strong understanding of the patient ...

In patients with high cardiovascular risk, statins are the first-line of therapy. Statins, such as Crestor® and Lipitor®, are economical and effective. However, for those patients who do ...